What is the level of liabilities of KMPharmaceutical Co this year?
KMPharmaceutical Co has a debt balance of 15.08 B KRW this year.
In 2024, KMPharmaceutical Co's total liabilities amounted to 15.08 B KRW, a 0.83% difference from the 14.95 B KRW total liabilities in the previous year.
KMPharmaceutical Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating KMPharmaceutical Co's financial stability, operational efficiency, and long-term viability.
By comparing KMPharmaceutical Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
KMPharmaceutical Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in KMPharmaceutical Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
KMPharmaceutical Co has a debt balance of 15.08 B KRW this year.
The liabilities of KMPharmaceutical Co have increased by 0.83% increased compared to the previous year.
High liabilities can pose a risk for investors of KMPharmaceutical Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that KMPharmaceutical Co has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of KMPharmaceutical Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of KMPharmaceutical Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of KMPharmaceutical Co include investments, acquisitions, operating costs, and sales development.
The liabilities of KMPharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, KMPharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, KMPharmaceutical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KMPharmaceutical Co is expected to pay a dividend of 0 KRW.
The current dividend yield of KMPharmaceutical Co is .
KMPharmaceutical Co pays a quarterly dividend. This is distributed in the months of .
KMPharmaceutical Co paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
KMPharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of KMPharmaceutical Co from 12/24/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.
The last dividend was paid out on 12/24/2024.
In the year 2023, KMPharmaceutical Co distributed 0 KRW as dividends.
The dividends of KMPharmaceutical Co are distributed in KRW.
Our stock analysis for KMPharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KMPharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.